Phase 2c Dose Comparison Study of MP4OX in Trauma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions
TraumaHemorrhagic ShockLactic Acidosis
Interventions
DRUG

MP4OX

4.3 g/dL pegylated hemoglobin in balanced lactate-electrolyte solution

DRUG

Control

Crystalloid solution IV infusion drip to keep vein open

Trial Locations (31)

Unknown

Liverpool Hospital, Liverpool

John Hunter Hospital, Newcastle

Erasme University Hospital, Brussels

University Hospital Antwerpen, Edegem

Faculdade de Medicina de S. J. Do Rio Preto, São José do Rio Preto

Hopital Universitário, Centro de Estudos em Emergências em Saúde, USP Ribeirão Preto, São Paulo

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - FMUSP, São Paulo

Hôpital Beaujon, Clichy

Hôpital du Kremlin Bicêtre, Le Kremlin-Bicêtre

Hôpital Roger Salengro, CHRU Lille, Lille

CHU Dupuytren, Limoges

Hôpital Edouard Herriot, Lyon

Hôpital Pitié-Salpêtrière, Paris

Universitätsklinikum der Rheinisch-Westfälische Technische Hochschule Aachen, Aachen

Campus Virchow Klinikum Charité Berlin, Berlin

Kliniken der Stadt Köln gGmbH Krankenhaus Merheim, Cologne

Klinikum der J.-W.-Goethe-Universität Frankfurt a.M., Franfurt

BG Klinik Ludwigshafen, Ludwigshafen

Soroka University Medical Center, Beersheba

Rambam Health Care Campus, Haifa

Hadassah Medical Organization, Hadassah University Hospital, Ein-Karem, Jerusalem

Auckland City Hospital, Auckland

Oslo University Hospital Ullevaal, Oslo

Netcare Union Hospital, Alberton

Vincent Palotti Dr Christiaan Barnard Memorial Hospital, Cape Town

Charlotte Maxeke Johannesburg Academic Hospita, Johannesburg

Netcare Milpark Hospital, Johannesburg

Chris Hani Baragwanath Hospital, Soweto

CHU Vaudois, Lausanne

UniversitätsSpital Zürich, Zurich

The Royal London Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sangart

INDUSTRY